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Abstract
The review surveys the impact of "stress hormones" - glucocorticoids and catecholamines - on
the functioning of the neuromuscular synapse. The review brings together the data on the
influence of the main agents of stress - Cortisol and norepinephrine - on the intensity and timing
of the acetylcholine release, as well as signaling effect of its co-mediator ATP.
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